Freedom Meditech is a private, growth-stage medical device company focused on the development and commercialization of first-to-market, non-invasive, ophthalmic medical devices that detect autofluorescence of the lens (ClearPath DS-120) and help monitor diabetes (I-SugarX).
In the U.S. there are about 25.8 million people with diabetes and another estimated 79 million with pre-diabetes. The World Health Organization estimates 220 million people live with diabetes worldwide today and will more than double by 2030.
The company operates out of two facilities. Corporate activities and product development are led from San Diego, California. Research and clinical studies for our diabetes monitoring device are performed throughout the state of Ohio.